Clinical Trial Update: Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)

View source ↗

Summary

A planned clinical trial to assess outcomes of radioactive iodine therapy (Iodine-131) in patients with differentiated thyroid cancer at low to intermediate ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Radioactive iodine therapy (I-131) (Iodine-131)

Snippet

Sponsor: Sohag University | Conditions: Thyroid Cancer | Status: NOT_YET_RECRUITING